178 related articles for article (PubMed ID: 28541594)
21. Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study.
Del Trigo M; Bergeron S; Bernier M; Amat-Santos IJ; Puri R; Campelo-Parada F; Altisent OA; Regueiro A; Eigler N; Rozenfeld E; Pibarot P; Abraham WT; Rodés-Cabau J
Lancet; 2016 Mar; 387(10025):1290-7. PubMed ID: 27025435
[TBL] [Abstract][Full Text] [Related]
22. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure.
Kaye D; Shah SJ; Borlaug BA; Gustafsson F; Komtebedde J; Kubo S; Magnin C; Maurer MS; Feldman T; Burkhoff D
J Card Fail; 2014 Mar; 20(3):212-21. PubMed ID: 24487087
[TBL] [Abstract][Full Text] [Related]
23. State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure.
Al-Sadawi M; Ortega RR; Ariyaratnam J; Battisha A; Madoukh B; Bukharovich I
Curr Cardiol Rev; 2021; 17(5):e230421189012. PubMed ID: 33305708
[TBL] [Abstract][Full Text] [Related]
24. Device therapy: Interatrial shunt device for HFpEF.
Lim GB
Nat Rev Cardiol; 2018 Jan; 15(1):4. PubMed ID: 29188804
[No Abstract] [Full Text] [Related]
25. Interatrial Shunting, a Novel Device-Based Therapy for Patients With Heart Failure.
Yum BKW; Frishman WH
Cardiol Rev; 2018; 26(5):267-273. PubMed ID: 30080749
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome of transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel implant.
Malek F; Neuzil P; Gustafsson F; Kaye DM; Walton A; Mates M; Søndergaard L; Ihlemann N; Mariani JA; Reddy V
Int J Cardiol; 2015; 187():227-8. PubMed ID: 25841123
[No Abstract] [Full Text] [Related]
27. Device Therapy for Heart Failure with Preserved Ejection Fraction.
Salah HM; Levin AP; Fudim M
Cardiol Clin; 2022 Nov; 40(4):507-515. PubMed ID: 36210134
[TBL] [Abstract][Full Text] [Related]
28. The sHunt for better breathing in heart failure with preserved ejection fraction.
Borlaug BA
Eur J Heart Fail; 2014 Jul; 16(7):709-11. PubMed ID: 24920438
[No Abstract] [Full Text] [Related]
29. Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction.
Riccardi M; Tomasoni D; Vizzardi E; Metra M; Adamo M
Heart Fail Rev; 2023 Mar; 28(2):315-330. PubMed ID: 36402928
[TBL] [Abstract][Full Text] [Related]
30. Comparison of device-based therapy options for heart failure with preserved ejection fraction: a simulation study.
Granegger M; Gross C; Siemer D; Escher A; Sandner S; Schweiger M; Laufer G; Zimpfer D
Sci Rep; 2022 Apr; 12(1):5761. PubMed ID: 35388023
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Inter-Atrial Shunt Devices for Heart Failure With Reduced or Preserved Ejection Fraction: Early Experiences.
Lu D; Zhu J; Liao B
Heart Lung Circ; 2018 Mar; 27(3):359-364. PubMed ID: 28483550
[TBL] [Abstract][Full Text] [Related]
32. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
Shah SJ; Borlaug BA; Chung ES; Cutlip DE; Debonnaire P; Fail PS; Gao Q; Hasenfuß G; Kahwash R; Kaye DM; Litwin SE; Lurz P; Massaro JM; Mohan RC; Ricciardi MJ; Solomon SD; Sverdlov AL; Swarup V; van Veldhuisen DJ; Winkler S; Leon MB;
Lancet; 2022 Mar; 399(10330):1130-1140. PubMed ID: 35120593
[TBL] [Abstract][Full Text] [Related]
33. Double Transseptal Access for Atrial Fibrillation Ablation in the Presence of Investigational Interatrial Shunt Device.
Guandalini GS; Mazurek JA; Dixit S
JACC Case Rep; 2021 Jan; 3(1):136-140. PubMed ID: 34317487
[TBL] [Abstract][Full Text] [Related]
34. Interatrial shunt devices for the treatment of heart failure.
Emani S; Burkhoff D; Lilly SM
Trends Cardiovasc Med; 2021 Oct; 31(7):427-432. PubMed ID: 33022385
[TBL] [Abstract][Full Text] [Related]
35. Left Atrial Decompression Using Unidirectional Left-to-Right Interatrial Shunt: Initial Experience in Treating Symptomatic Heart Failure With Preserved Ejection Fraction With the W-Wave Device.
Amat-Santos IJ; Del Trigo M; Bergeron S; Pibarot P; Altisent O; Campelo-Parada F; Puri R; Verheye S; Keren G; Katzenellenbogen R; Rozenfeld E; Abraham WT; Bernier M; Rodés-Cabau J
JACC Cardiovasc Interv; 2015 May; 8(6):870-872. PubMed ID: 25999114
[No Abstract] [Full Text] [Related]
36. Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction.
Kaye DM; Nanayakkara S
Front Cardiovasc Med; 2019; 6():143. PubMed ID: 31620452
[TBL] [Abstract][Full Text] [Related]
37. Mechanical and interventional support for heart failure with preserved ejection fraction: A review.
Gordon JS; Blazoski CM; Wood CT; Zuber C; Massey HT; Throckmorton A; Tchantchaleishvili V
Artif Organs; 2022 Nov; 46(11):2109-2117. PubMed ID: 35579447
[TBL] [Abstract][Full Text] [Related]
38. Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure.
Griffin JM; Borlaug BA; Komtebedde J; Litwin SE; Shah SJ; Kaye DM; Hoendermis E; Hasenfuß G; Gustafsson F; Wolsk E; Uriel N; Burkhoff D
J Am Heart Assoc; 2020 Sep; 9(17):e016760. PubMed ID: 32809903
[TBL] [Abstract][Full Text] [Related]
39. Interatrial Dyssynchrony May Contribute to Heart Failure Symptoms in Patients with Preserved Ejection Fraction.
Sanchis L; Vannini L; Gabrielli L; Duchateau N; Falces C; Andrea R; Bijnens B; Sitges M
Echocardiography; 2015 Nov; 32(11):1655-61. PubMed ID: 25732145
[TBL] [Abstract][Full Text] [Related]
40. Advances in device-based treatment of heart failure with preserved ejection fraction: evidence from clinical trials.
Wu Y; Song M; Wu M; Lin L
ESC Heart Fail; 2024 Feb; 11(1):13-27. PubMed ID: 37986663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
